BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24009163)

  • 1. Visual evoked potentials in neuromyelitis optica and its spectrum disorders.
    Ringelstein M; Kleiter I; Ayzenberg I; Borisow N; Paul F; Ruprecht K; Kraemer M; Cohn E; Wildemann B; Jarius S; Hartung HP; Aktas O; Albrecht P
    Mult Scler; 2014 Apr; 20(5):617-20. PubMed ID: 24009163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features of anti-aquaporin 4 antibody-seropositive Chinese patients with neuromyelitis optica spectrum optic neuritis.
    Li H; Wang Y; Xu Q; Zhang A; Zhou H; Zhao S; Kang H; Peng C; Cao S; Wei S
    J Neurol; 2015 Oct; 262(10):2293-304. PubMed ID: 26162715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between aquaporin-4 antibody status and visual tract integrity in neuromyelitis optica spectrum disorders: A visual evoked potential study.
    Barć K; Gospodarczyk-Szot K; Nojszewska M; Podlecka-Piętowska A; Zakrzewska-Pniewska B
    Mult Scler Relat Disord; 2020 Sep; 44():102265. PubMed ID: 32575026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease?
    Papais Alvarenga RM; Araújo ACRAE; Nascimento ACB; Araujo NEC; Meneguette NS; Neri VC; Papais Alvarenga M; Filho HA; Barros PO; Bento CA; Schmidt SL; Vasconcelos CCF; Alvarenga MP
    Mult Scler Relat Disord; 2020 Jul; 42():102082. PubMed ID: 32361664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.
    Magaña SM; Pittock SJ; Lennon VA; Keegan BM; Weinshenker BG; Lucchinetti CF
    Arch Neurol; 2009 Aug; 66(8):964-6. PubMed ID: 19667216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
    Collongues N; Marignier R; Jacob A; Leite MI; Siva A; Paul F; Zephir H; Akman-Demir G; Elsone L; Jarius S; Papeix C; Mutch K; Saip S; Wildemann B; Kitley J; Karabudak R; Aktas O; Kuscu D; Altintas A; Palace J; Confavreux C; De Seze J
    Mult Scler; 2014 Jul; 20(8):1086-94. PubMed ID: 24323817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromyelitis Optica Spectrum Disorders.
    Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K
    Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal segmented layers with strong aquaporin-4 expression suffered more injuries in neuromyelitis optica spectrum disorders compared with optic neuritis with aquaporin-4 antibody seronegativity detected by optical coherence tomography.
    Peng CX; Li HY; Wang W; Wang JQ; Wang L; Xu QG; Cao SS; Zhou HF; Zhao S; Wei SH
    Br J Ophthalmol; 2017 Aug; 101(8):1032-1037. PubMed ID: 28057643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
    J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
    Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
    Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of AQP4 Antibody Serostatus and its Prediction of Visual Outcome in Neuromyelitis Optica: A Systematic Review and Meta-Analysis.
    Lin N; Liu Q; Wang X; Ma J; Li Y
    Protein Pept Lett; 2017; 24(3):245-252. PubMed ID: 28071581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
    Kim SM; Waters P; Woodhall M; Kim JY; Kim JE; Yang JW; Kim JS; Sung JJ; Park KS; Lee KW
    Mult Scler; 2013 Jul; 19(8):1060-7. PubMed ID: 23329699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromyelitis optica antibodies in patients with severe optic neuritis in China.
    Lai C; Tian G; Takahashi T; Liu W; Yang L; Zhang X
    J Neuroophthalmol; 2011 Mar; 31(1):16-9. PubMed ID: 21150455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
    Kitley J; Leite MI; Nakashima I; Waters P; McNeillis B; Brown R; Takai Y; Takahashi T; Misu T; Elsone L; Woodhall M; George J; Boggild M; Vincent A; Jacob A; Fujihara K; Palace J
    Brain; 2012 Jun; 135(Pt 6):1834-49. PubMed ID: 22577216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of intravenous methylprednisolone pulse therapy on recurrent optic neuritis associated with aquaporin 4 antibody seropositive neuromyelitis optica].
    Guo ST; Li Z; Jiang LB; Wu RH; Peng JT; Wang JW; Wei WB
    Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):509-513. PubMed ID: 32842332
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuromyelitis optica spectrum disorders (NMO-SD) in a Sub-Saharan Africa country: A preliminary study of sixteen Senegalese cases.
    Gaye NM; Fall M; Diop AM; Dadah SML; Ka M; Cissé O; Diagne NS; Diop-Sène MS; Sow AD; Basse-Faye AM; Sarr MM; Touré K; Seck LB; Ndiaye M; Diop AG
    Mult Scler Relat Disord; 2019 Jan; 27():179-183. PubMed ID: 30388487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical presentations of neuromyelitis optica.
    Sato D; Fujihara K
    Arq Neuropsiquiatr; 2011 Oct; 69(5):824-8. PubMed ID: 22042189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-aquaporin-4 antibody-positive familial neuromyelitis optica in mother and daughter.
    Yoshimine S; Sakai T; Ogasawara M; Shikishima K; Tsuneoka H; Tanaka K
    Jpn J Ophthalmol; 2011 Nov; 55(6):647-50. PubMed ID: 21909659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica.
    Akaishi T; Nakashima I; Takeshita T; Mugikura S; Sato DK; Takahashi T; Nishiyama S; Kurosawa K; Misu T; Nakazawa T; Aoki M; Fujihara K
    J Neuroimmunol; 2016 Apr; 293():28-33. PubMed ID: 27049558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.